Carregant...
Approaches to Optimizing Dantrolene Neuroprotection for the Treatment of Alzheimer’s Disease
Alzheimer’s Disease (AD), a neurodegenerative disorder with high incidence and mortality, is leading its way to the top of the list of the deadliest diseases without an effective disease-modifying drug. Ca(2+) dysregulation, specifically abnormal release of Ca(2+) via over activated ryanodine recept...
Guardat en:
| Publicat a: | Curr Alzheimer Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7705762/ https://ncbi.nlm.nih.gov/pubmed/32442084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1567205017666200522204722 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|